Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
1,424,343
-
Share change
-
-3,423,207
-
Total reported value
-
$4,011,037
-
Put/Call ratio
-
118%
-
Price per share
-
$2.81
-
Number of holders
-
27
-
Value change
-
-$9,544,830
-
Number of buys
-
7
-
Number of sells
-
13
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q2 2021
As of 30 Jun 2021 BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,424,343 shares of stock of the company.
Largest 10 holders included Parkman Healthcare Partners LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, LPL Financial LLC, CITADEL ADVISORS LLC, Intellectus Partners, LLC, Game Plan Financial Advisors, LLC, ACT Capital Management, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and Cutter & CO Brokerage, Inc..
This table shows 27 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.